8.46 +0.22 (2.65%)
VVUS
Stock Details
Last Trade:8.46 Change:+0.22 (2.65%) Prev Close:8.24 Open: 8.31 Days Range:8.17 – 8.50 52 Week Range: 2.72 - 12.88 Volume:2353091 P/E: N/AEPS:-0.70
View AllRecent Alerts 02/10/10
Recent Alert on 01/26/10 at 11:53am
Merriman Curhan Ford Reiterates a 'Buy' on Vivus, Inc (VVUS)
Merriman Curhan Ford Reiterates a 'Buy' on Vivus, Inc (VVUS)
Merriman Curhan Ford reiterates a 'Buy' on Vivus, Inc (Nasdaq: VVUS), price target range $16-18. Merriman analyst says, "In our opinion, the approval of Victoza (and, by analogy, EOW [PDUFA date March 5]) bodes well for the approval of Qnexa. The... Read More
Recent Alert on 01/11/10 at 7:28am
VIVUS (VVUS) Announces Positive Results for Avanafil Phase 3 for ED
VIVUS (VVUS) Announces Positive Results for Avanafil Phase 3 for ED
Recent Alert on 01/11/10 at 7:28am
VIVUS (VVUS) Announces Positive Results for Avanafil Phase 3 for ED
VIVUS (VVUS) Announces Positive Results for Avanafil Phase 3 for ED
Recent Alert on 01/07/10 at 7:08am
VIVUS (VVUS) Trial Shows Qnexa Effective In Treatment of Sleep Apnea
VIVUS (VVUS) Trial Shows Qnexa Effective In Treatment of Sleep Apnea
Recent Alert on 01/06/10 at 5:46pm
After-Hours Movers 01/06: ZUMZ, INSP, RT, BBBY, SHAW Higher; CBK, ZGEN, TSRA, HOTT, VVUS Lower
After-Hours Movers 01/06: ZUMZ, INSP, RT, BBBY, SHAW Higher; CBK, ZGEN, TSRA, HOTT, VVUS Lower
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/19/09 at 11:37am
CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q